These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 792516)

  • 21. A new congenital abnormality of human fibrinogen. Fibrinogen Bethesda II.
    Gralnick HR; Givelber HM; Finlayson JS
    Thromb Diath Haemorrh; 1973 Jun; 29(3):562-71. PubMed ID: 4761824
    [No Abstract]   [Full Text] [Related]  

  • 22. [Determination of the sterol content in fibrinogen as a method of diagnosing the progression of arteriosclerosis].
    Kondrat'eva LG; Vendt VP; Govseeva NN; Solovtsova KM
    Vrach Delo; 1978 Jul; (7):26-8. PubMed ID: 685250
    [No Abstract]   [Full Text] [Related]  

  • 23. [Biological half-life of fibrinogen labelled with radioactive iodine I-131 in coronary disease].
    Dordević BS; Bosnjaković V; Baklaja-Jevremović R; Nastić D
    Acta Med Iugosl; 1970; 24(1):7-19. PubMed ID: 5201592
    [No Abstract]   [Full Text] [Related]  

  • 24. [Symposium on the cerebral stroke. (5) Studies on the aspect of plasma fibrinogen and serum lipids relating to apoplexy (author's transl)].
    Kuzuya F; Yoshmine N
    Nihon Naika Gakkai Zasshi; 1976 Dec; 65(12):1373-9. PubMed ID: 1035244
    [No Abstract]   [Full Text] [Related]  

  • 25. Fibrinogen and coronary heart disease--what does it mean?
    Oliver MF
    Eur Heart J; 1998 Jan; 19(1):8-9. PubMed ID: 9503169
    [No Abstract]   [Full Text] [Related]  

  • 26. [Blood sterol-fibrinogen complexes in chronic ischemic heart disease].
    Revutskiĭ EL; Palamarchuk VI; Vendt VP; Fedorishko SS
    Vrach Delo; 1979 Sep; (9):43-5. PubMed ID: 494607
    [No Abstract]   [Full Text] [Related]  

  • 27. [Determination of plasma fibrinogen and fibrin degradation products (FDP) in 100 normal persons and 32 cases of acute cerebrovascular disease (author's transl)].
    Wang GX
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Feb; 15(1):8-10. PubMed ID: 7094732
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparison of the plasma lipid pattern in patients with coronary and cerebral vascular diseases].
    Picchi M; Pepi F
    Boll Soc Ital Biol Sper; 1976 May; 52(9):639-41. PubMed ID: 949452
    [No Abstract]   [Full Text] [Related]  

  • 29. [Simplified method for clinical evaluation of the hexoses of fibrinogen].
    Recalcati P; Pagliano F; Rugarli C
    Haematol Lat; 1967; 10(4):395-407. PubMed ID: 5593509
    [No Abstract]   [Full Text] [Related]  

  • 30. [Blood fibrinogen-bound sterols in ischemic heart disease].
    Fedorishko SS; Palamarchuk VI
    Vrach Delo; 1979 Nov; (11):20-2. PubMed ID: 524809
    [No Abstract]   [Full Text] [Related]  

  • 31. Fibrinogen and factor VII as risk factors in vascular disease.
    Hultin MB
    Prog Hemost Thromb; 1991; 10():215-41. PubMed ID: 2008532
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage.
    Bell SF; Rayment R; Collins PW; Collis RE
    Int J Obstet Anesth; 2010 Apr; 19(2):218-23. PubMed ID: 20194010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrinogen Montreal. A new case of congenital dysfibrinogenemia with defective aggregation of monomers.
    Lacombe M; Soria J; Soria C; D'Angelo G; Lavallee R; Bonny Y
    Thromb Diath Haemorrh; 1973 Jun; 29(3):536-46. PubMed ID: 4761822
    [No Abstract]   [Full Text] [Related]  

  • 34. [Fibrinogen, a cardiovascular risk factor].
    Ferrara E; Cucchi G; Sardeo C
    Minerva Cardioangiol; 1989 Nov; 37(11):473-5. PubMed ID: 2622536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Heparin-induced extracorporeal LDL precipitation (HELP): a new therapeutic intervention in cerebrovascular diseases and peripheral arterial occlusive disease].
    Walzl B; Walzl M; Lechner P; Lechner H; Cesnik H
    Wien Med Wochenschr; 1993; 143(22):563-70. PubMed ID: 8154130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute promyelocytic leukemia with fibrinogen and factor 13 deficiencies.
    Karaca M; Tartaroğlu N; Yavuzgil C; Kabakçi T; Kocabaş A
    New Istanbul Contrib Clin Sci; 1971; 10(1):1-8. PubMed ID: 5291959
    [No Abstract]   [Full Text] [Related]  

  • 37. [Lipid levels and vascular accidents in Senegalese patients. (comparative study of 53 patients and 53 controls].
    Klotz F; Thomas J; Renambot J; Mayère JP
    Dakar Med; 1981; 26(2):252-5. PubMed ID: 7333204
    [No Abstract]   [Full Text] [Related]  

  • 38. [On changes in the level of fibrinogen in cerebral disorders].
    Ashman AA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(9):1345-9. PubMed ID: 6000202
    [No Abstract]   [Full Text] [Related]  

  • 39. [Afibrinogenemia and dysfibrinogenemia].
    Fukui H
    Nihon Rinsho; 1970 Aug; 28(8):2086-91. PubMed ID: 4917925
    [No Abstract]   [Full Text] [Related]  

  • 40. [Case of hypofibrinogenemia with disorders of fibrin polymerization during hepatic cirrhosis].
    Gouault-Heilmann M; Chardon E; Yvart J; Sultan C; Cattan D
    Pathol Biol (Paris); 1974 Nov; 22 suppl():80-5. PubMed ID: 4620100
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.